Shuang Liu

State Key Laboratory Of Medical Genomics
Shanghai, 200025, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

SrcE97A Mediates Convergent Regulation of Arterial/Venous Thrombosis and Immune Homeostasis via β3-Src Dissociation.

SrcE97A Mediates Convergent Regulation of Arterial/Venous Thrombosis and Immune Homeostasis via β3-Src Dissociation.

Journal: Journal of thrombosis and haemostasis : JTH

Published: February 11, 2026

Integrin β3 deficiency unleashes spontaneous pulmonary inflammation by promoting B cell hyperactivation via the CD40-CD40L axis.

Integrin β3 deficiency unleashes spontaneous pulmonary inflammation by promoting B cell hyperactivation via the CD40-CD40L axis.

Journal: Frontiers in immunology

Published: January 28, 2026

Potent Inhibition of Arterial Thrombosis and Venous Thrombogenesis Subject to Adequate Hemostasis via Disrupting β3/Src Interaction in Platelets.

Potent Inhibition of Arterial Thrombosis and Venous Thrombogenesis Subject to Adequate Hemostasis via Disrupting β3/Src Interaction in Platelets.

Journal: Thrombosis and haemostasis

Published: October 10, 2025

The critical role of platelets in venous thromboembolism: Pathogenesis, clinical status, and emerging therapeutic strategies.

The critical role of platelets in venous thromboembolism: Pathogenesis, clinical status, and emerging therapeutic strategies.

Journal: Blood reviews

Published: March 03, 2025

Dedicator of cytokinesis 2 regulates cytoskeletal actin dynamics and is essential for platelet biogenesis and functions.

Dedicator of cytokinesis 2 regulates cytoskeletal actin dynamics and is essential for platelet biogenesis and functions.

Journal: Cardiovascular research

Published: October 16, 2024

Thrombotic events associated with immune checkpoint inhibitors and novel antithrombotic strategies to mitigate bleeding risk.

Thrombotic events associated with immune checkpoint inhibitors and novel antithrombotic strategies to mitigate bleeding risk.

Journal: Blood reviews

Published: April 26, 2024

PD-L1 targeted peptide demonstrates potent antitumor and immunomodulatory activity in cancer immunotherapy.

PD-L1 targeted peptide demonstrates potent antitumor and immunomodulatory activity in cancer immunotherapy.

Journal: Frontiers in immunology

Published: January 08, 2024

Nanoscale hematoporphrin-based frameworks for photo-sono synergistic cancer therapy via utilizing Al(III) as metal nodes rather than heavy metals.

Nanoscale hematoporphrin-based frameworks for photo-sono synergistic cancer therapy via utilizing Al(III) as metal nodes rather than heavy metals.

Journal: Journal of colloid and interface science

Published: November 09, 2021

Showing 1-8 of 8

Last Updated: 09/26/2026